daunorubicin has been researched along with alpha-chymotrypsin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duncan, R; Kopecek, J; Subr, V | 1 |
| Fekete, MR; McBride, WH; Pajonk, F | 1 |
2 other study(ies) available for daunorubicin and alpha-chymotrypsin
| Article | Year |
|---|---|
Release of macromolecules and daunomycin from hydrophilic gels containing enzymatically degradable bonds.
Topics: Amino Acid Sequence; Animals; Biodegradation, Environmental; Chymotrypsin; Daunorubicin; Dextrans; Fluorescein-5-isothiocyanate; Fluoresceins; Gels; Kinetics; Liver; Molecular Sequence Data; Molecular Structure; Oligopeptides; Polymethacrylic Acids; Rats | 1990 |
Anthracyclines, proteasome activity and multi-drug-resistance.
Topics: Anthracyclines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Chymotrypsin; Cyclosporine; Cysteine Proteinase Inhibitors; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Leupeptins; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Transfection | 2005 |